Articles

Positioning pharmaceuticals: an expert view

17 November 2020

Mike Rea, CEO of IDEA Pharma, has worked on some successful new drug and medical product launches over the last 20 years. His new book, Pharmaceutical Positioning (now available on Amazon), is he claims, the world’s first book on positioning pharmaceuticals. As a discipline, positioning emerged in the 20th century as a powerful concept in product […]

Life sciences report highlights implications of early COVID-19 vaccines data

12 November 2020

FinnCap’s latest Rude Health Life Sciences Sector Report focuses on the implications of early COVID-19 vaccine data. This comes as Pfizer and BioNTech have announced their COVID-19 vaccine candidate has so far been found to be 90% effective in preventing COVID-19. Mark Brewer, Director of Research for finnCap, commented: “While the results are very promising, we […]

Gut feeling: why microbiomes holds so much promise for targeted therapeutics

3 November 2020

Charlie Badham, Corporate Development, 4D pharma, spoke to Lu Rahman about the growing significance of microbiomics in the quest for new therapeutics   LR: How important are microbiomics in the development of new therapeutics and how does understanding gut bacteria help us find treatments for new diseases? CB: The microbiome and live biotherapeutic products (LBPs) […]

Tapping a staggering market potential

23 October 2020

Dr Michael Shepard and Sir Marc Feldmann, Enosi Life Sciences, examine the benefits of distinguishing between TNF receptors Siloed thought processes are potentially costing the pharmaceutical industry billions of dollars per year. One particularly interesting case is that of autoimmune diseases and cancer. These two areas of medicine have a very important link – inflammation […]

Keeping the cold chain unbroken for COVID research and vaccine development

13 October 2020

Robin Vacha, Senior Vice President, Products at Brooks Life Sciences and David Lewandowski, Global Business Development Manager, Cryo Division at Brooks Life Sciences examine the role of unbroken cold chain in research and development As COVID-19 vaccine research continues to grow at an unparalleled pace, so does the need for -800 C storage in the […]

Automated flow cytometry analysis tools unlock pharma research insights

12 October 2020

Tariq E. Khoyratty DPhil, Computational Biologist, Aigenpulse, and Satnam Surae PhD, Chief Product Officer, Aigenpulse, discuss the challenge of the large volume of data generated and how automation/AI/ML can help to manage this. As pharmaceutical companies expand their research and development (R&D) efforts to meet the growing global demand for new drugs, the need for efficient analysis […]

Pharmacovigilance audits: implications of poor pass rates for drug developers

12 October 2020

Vanessa Fachada Oliveira, Pharmacovigilance Manager & EU QPPV at Arriello, discusses 10 common issues identified in risk-based audits, and pinpoints implications for drug developers as well as marketing authorisation holders (MAHs). In EU markets, pharmacovigilance (PV) provisions are closely monitored to ensure that patients can have maximum confidence in the safety of the products they take. […]

Analytical thinking: a focus on cell & gene therapeutic analysis

2 October 2020 , By Lu Rahman

Absorption Systems works collaboratively with biotech and pharma companies. Dealing with their future therapeutics, the company’s analytical research services help customers streamline and simplify the approval process. Lu Rahman found out more from CEO Patrick Dentinger. LR: Describe Absorption Systems’ analytical testing expertise in relation to cell and gene therapy PD: As an analytical lab, customers […]

Stop, collaborate and listen: a model for successful pharma and vendor engagement

1 October 2020 , By Szczepan W. Baran

Digital transformations are having wide-ranging and profound impacts within life sciences, creating both opportunities and challenges. One of those challenges is adopting new software systems to drive the transformations. Pharma invests in powerful software technologies with the promise of increased efficiencies, but ultimately, if the interfaces are unintuitive and more difficult than current processes, end […]

DDW App note: When to outsource to an integrated drug discovery team

1 October 2020

This paid-for app note by Eurofins appeared in DDW Volume 21, Issue 4 – Fall 2020. Despite the chaos of 2020, drug discovery has powered on, allbeit with some adaptations. One change has been the increased demand for outsourcing services, particularly from small and mid-sized pharma and biopharma companies eager to cut costs and gain access […]

« Previous
Next »

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free